Covers:
Age, age-related diseases, male sex, aging mortality as opposed to COVID-19 mortality, age-related diseases, cytokine storms such as hyperfunction, Theory of near-programmed aging hyperfunction, vulnerability to COVID-19 as age-related syndrome, inflammation-aging and immunosenescence, cell senescence as continuation of growth, Figuratively speaking, rapamycin rejuvenates immunity, anti-aging medicine, Rapamycin and everolimus as anti-aging drugs and, Potential programs of rapamycin/erolilimus to COVID-19